H.B. Fuller Acquires Advanced Medical Solutions for £660M, Bolstering Medical Adhesives Technology and Global Footprint

July 26, 2026

Perivan USA

Overview

H.B. Fuller announced its recommended cash acquisition of Advanced Medical Solutions Group plc (AMS), a UK-based developer and manufacturer of innovative tissue-healing technologies, for approximately £660 million. AMS offers a wide range of surgical products, including LiquiBand® tissue adhesives, sutures, and hemostats. This acquisition will significantly strengthen H.B. Fuller’s product portfolio and global presence in medical adhesive technologies, establishing its leadership in the high-growth medical market.

In Depth

Key Findings

H.B. Fuller has announced its intention to acquire Advanced Medical Solutions Group plc (AMS), a UK-based company specializing in the development and manufacturing of innovative tissue-healing technologies, for approximately £660 million (approximately $1.28 billion USD) through a recommended cash acquisition scheme. This major acquisition represents a strategic leap for H.B. Fuller to substantially reinforce its global standing in the medical adhesives and surgical products market.

Technical & Business Details

AMS’s Core Products: AMS provides a diverse array of high-quality surgical products, notably its proprietary LiquiBand® brand of tissue adhesives, along with surgical sutures and hemostats. These products play critical roles in clinical settings for bleeding control, wound closure, and reduction of scar formation during surgical procedures.
H.B. Fuller’s Portfolio Enhancement: This acquisition will significantly enhance H.B. Fuller’s existing medical adhesive product lineup by integrating AMS’s innovative technologies and products. The company’s expertise will deepen particularly in high-value areas such as biocompatible adhesives and tissue sealants.
Expansion of Global Presence: The integration of AMS’s established international sales network with H.B. Fuller’s existing channels will enable both companies’ medical products to reach broader markets. This move specifically strengthens H.B. Fuller’s presence in Europe and other growth markets.

Background & Industry Context

The demand for adhesives and sealants in the medical sector is steadily growing, driven by the increasing adoption of minimally invasive surgeries, the need to reduce infection risks, and advancements in patient recovery. Tissue adhesives, as alternatives to traditional sutures and staples, are gaining accelerated adoption due to their potential to shorten surgical times and reduce complication risks. H.B. Fuller prioritizes innovation and market share capture in this high-growth market.Strategic Significance & Outlook

The acquisition of Advanced Medical Solutions is pivotal for H.B. Fuller to solidify its position as a leader in the medical technology industry. The integrated business is expected to expand investments in research and development, accelerating the creation of next-generation wound healing and surgical adhesive solutions. Through this, H.B. Fuller anticipates continuing to offer innovative products that contribute to improved patient care, enhanced surgical efficiency for healthcare professionals, and reduced healthcare costs. This move has the potential to reshape the competitive landscape of the medical adhesives market.

Source: https://www.perivan.com/resources/news/scheme-document-published-for-the-660-million-recommended-cash-acquisition-by-h-b-fuller-for-advanced-medical-solutions/

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.